Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2959

1.

Higher preprocedural fibrinogen levels are associated with aneurysm sac regression after EVAR.

Rašiová M, Koščo M, Špak Ľ, Moščovič M, Židzik J, Slabá E, Habalová V, Farkašová Ľ, Hudák M, Tkáč I.

Vasa. 2019 Mar 15:1-8. doi: 10.1024/0301-1526/a000783. [Epub ahead of print]

PMID:
30874486
2.

Acquired arteriovenous fistula of a finger.

Rietig R, Hudak S, Hieronimus A, Lehn-Stefan A, Balletshofer B, Häring HU, Syha R, Randrianarisoa E.

Vasa. 2019 Mar 15:1-3. doi: 10.1024/0301-1526/a000784. [Epub ahead of print]

PMID:
30874481
3.

The influence of May-Thurner syndrome on post-thrombotic syndrome in young women.

Kovač A, Janić M, Nuredini D, Kozak M.

Vasa. 2019 Mar 8:1-6. doi: 10.1024/0301-1526/a000776. [Epub ahead of print]

PMID:
30848698
4.

A near-infrared spectroscopy-assisted test discriminates patients with peripheral arterial disease and venous insufficiency with changes of foot oxygenation following light elastic compression therapy.

Lamberti N, Manfredini F, Tessari M, Menegatti E, Nardi F, Basaglia N, Zamboni P.

Vasa. 2019 Mar 6:1-7. doi: 10.1024/0301-1526/a000780. [Epub ahead of print]

PMID:
30838936
5.

Impact of lowering blood pressure on patients with PAD - of sowing the wind and reaping the whirlwind?

[No authors listed]

Vasa. 2019 Mar;48(2):196. doi: 10.1024/0301-1526/a000761. No abstract available.

PMID:
30821215
6.

Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic.

Zeller T, Noory E, Beschorner U, Böhme T, Mpj Reijnen M.

Vasa. 2019 Mar;48(2):109-111. doi: 10.1024/0301-1526/a000778. No abstract available.

PMID:
30821214
7.

ESVM integrated care pathways - a call for action.

Visonà A, Pesavento R, Mazzolai L, Cimminiello C, Pécsvárady Z, Olinic D, Johansson E.

Vasa. 2019 Mar;48(2):113-114. doi: 10.1024/0301-1526/a000755. No abstract available.

PMID:
30821213
8.

Safety, procedural success and outcome of the Aspirex®S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis - data from the Arnsberg Aspirex registry.

Lichtenberg M, Stahlhoff WF, Özkapi A, de Graaf R, Breuckmann F.

Vasa. 2019 Feb 20:1-6. doi: 10.1024/0301-1526/a000779. [Epub ahead of print]

PMID:
30785373
9.

May-Thurner syndrome - Are we aware enough?

Mako K, Puskas A.

Vasa. 2019 Feb 20:1-8. doi: 10.1024/0301-1526/a000775. [Epub ahead of print]

PMID:
30785369
10.

Reversal strategies in patients treated with direct oral anticoagulants.

Gressenberger P.

Vasa. 2019 Feb 5:1-4. doi: 10.1024/0301-1526/a000777. [Epub ahead of print]

PMID:
30719950
11.

Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.

Sebastian T, Engelberger RP, Spirk D, Hakki LO, Baumann FA, Spescha RS, Kucher N.

Vasa. 2019 Jan 22:1-9. doi: 10.1024/0301-1526/a000774. [Epub ahead of print]

PMID:
30667348
12.

Breaking the exclusiveness of LMWH for treating cancer-associated VTE.

Tuleja A, Thalhammer C.

Vasa. 2019 Jan;48(1):99. doi: 10.1024/0301-1526/a000739. No abstract available.

PMID:
30652943
13.

Diagnostic work-up and endovascular treatment of traumatic and non-traumatic vascular emergencies.

Partovi S, Ghoshhajra BB.

Vasa. 2019 Jan;48(1):5. doi: 10.1024/0301-1526/a000769. No abstract available.

PMID:
30608216
14.

Extracranial internal carotid artery occlusive dissection - multimodality presentation in a case series.

Rafailidis V, Notas K, Destanis E, Kouskouras K, Chryssogonidis I, Xerras C, Charitanti-Kouridou A, Tegos T.

Vasa. 2018 Dec 12:1-7. doi: 10.1024/0301-1526/a000768. [Epub ahead of print]

PMID:
30539689
15.

Cohort study of risk factors for 30-day readmission after abdominal aortic aneurysm repair.

Bath J, Smith JB, Kruse RL, Vogel TR.

Vasa. 2018 Dec 12:1-11. doi: 10.1024/0301-1526/a000767. [Epub ahead of print]

PMID:
30539688
16.

Diabetes and smoking are more important for prognosis of patients with peripheral arterial disease than some genetic polymorphisms.

Boc V, Božic Mijovski M, Pohar Perme M, Blinc A.

Vasa. 2018 Dec 11:1-7. doi: 10.1024/0301-1526/a000766. [Epub ahead of print]

PMID:
30526437
17.

Patency rates, safety and clinical results of the sinus-Obliquus venous stent in the treatment of chronic ilio-femoral venous outflow obstruction - data from the Arnsberg venous registry.

Lichtenberg M, de Graaf R, Stahlhoff WF, Özkapi A, Simon M, Breuckmann F.

Vasa. 2018 Dec 10:1-6. doi: 10.1024/0301-1526/a000772. [Epub ahead of print]

PMID:
30526435
18.

Multiple arteriovenous malformations caused by RASA1 gene mutation presenting during pregnancy - a case report and review of the literature.

Manzocchi Besson S, Jastrow Meyer N, Bounameaux H, La Scala GC, Calza AM, Yilmaz H, Righini M, Robert-Ebadi H.

Vasa. 2018 Dec 10:1-5. doi: 10.1024/0301-1526/a000770. [Epub ahead of print]

PMID:
30526434
19.

Multidisciplinary team decision is rare and decreasing in percutaneous vascular interventions despite positive impact on in-hospital outcomes.

Behrendt CA, Kölbel T, Schwaneberg T, Diener H, Hohnhold R, Debus ES, Rieß HC.

Vasa. 2018 Dec 10:1-8. doi: 10.1024/0301-1526/a000771. [Epub ahead of print]

20.

Arterial stiffness and subclinical aortic damage of reclassified subjects as stage 1 hypertension according to the new 2017 ACC/AHA blood pressure guidelines.

Papaioannou TG, Oikonomou E, Lazaros G, Christoforatou E, Vogiatzi G, Tsalamandris S, Chasikidis C, Kalambogias A, Mavratzas T, Stofa E, Mystakidi VC, Latsios G, Deftereos S, Tousoulis D.

Vasa. 2018 Dec 10:1-8. doi: 10.1024/0301-1526/a000765. [Epub ahead of print]

PMID:
30526401

Supplemental Content

Support Center